α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
Tracy A. Cole, Hien Zhao, Timothy J. Collier et al. · JCI Insight · 2021
Full textCC BY
Clinical Neurology
Filters3 filters applied
Year
Readable here
1 paperQuestions on this topic